Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hexis is a private digital health and sports nutrition technology company that provides an AI-driven platform for personalized fueling and recovery planning for athletes and teams. The company translates workout data, physiology, exercise metabolism, and nutrition science into adaptive nutrition plans that help improve athletic performance and recovery. Its software integrates training and wearable data to automate individualized carbohydrate and energy recommendations at scale for coaches, teams, and high-performance organizations. Hexis appears to operate commercially in the sports performance market rather than as a therapeutics developer, and it is not a biotech or pharmaceutical drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hexis.